These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2095702)

  • 1. Cytogenetic survey of sixty-one patients with preleukemic syndrome including myeloproliferative and myelodysplastic diseases.
    Palka G; Spadano A; Calabrese G; Parruti G; Guanciali Franchi P; Di Sante O; Recchia A; Di Lorenzo R; Torlontano G
    Ann Genet; 1990; 33(4):214-8. PubMed ID: 2095702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chromosomal changes in 20 patients with myelodysplastic disorders (preleukemias)].
    Zapata Gayón N; Cruz Mendoza AM; Pizzuto J; González Angulo A
    Sangre (Barc); 1985; 30(4-A):430-8. PubMed ID: 4071356
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
    Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
    Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome.
    Kakazu N; Taniwaki M; Horiike S; Nishida K; Tatekawa T; Nagai M; Takahashi T; Akaogi T; Inazawa J; Ohki M; Abe T
    Genes Chromosomes Cancer; 1999 Dec; 26(4):336-45. PubMed ID: 10534769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
    Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
    Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
    Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
    Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
    Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases.
    Beyer V; Mühlematter D; Parlier V; Cabrol C; Bougeon-Mamin S; Solenthaler M; Tobler A; Pugin P; Gregor M; Hitz F; Hess U; Chapuis B; Laurencet F; Schanz U; Schmidt PM; van Melle G; Jotterand M
    Cancer Genet Cytogenet; 2005 Jul; 160(2):97-119. PubMed ID: 15993266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion (11)(q13) as the sole anomaly in myeloid malignancies: four new cases and a short review.
    Panani AD; Pappa V; Papageorgiou S; Stamatelli F; Raptis SA
    Ann Hematol; 2004 Mar; 83(3):153-5. PubMed ID: 15064863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of cytogenetic abnormalities involving chromosomes 5,7 and 8 in myelodysplastic syndromes with fluorescence in situ hybridization and its clinical significance].
    Cai Y; Qin YW; Wang C; Yang J; Yan SK
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):6-10. PubMed ID: 17649717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic evidence of Y chromosome loss in male patients with hematological disorders.
    Zhang LJ; Shin ES; Yu ZX; Li SB
    Chin Med J (Engl); 2007 Nov; 120(22):2002-5. PubMed ID: 18067786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique cytogenetic features of primary myelodysplastic syndromes in Chinese patients.
    Li L; Liu XP; Nie L; Yu MH; Zhang Y; Qin TJ; Xiao ZJ
    Leuk Res; 2009 Sep; 33(9):1194-8. PubMed ID: 19128829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relation of karyotypic findings to chemotherapy response in patients with preleukemia].
    Horiike S; Taniwaki M; Nakagawa H; Tanaka S; Tsuda S; Misawa S; Inazawa J; Sonoda Y; Abe T; Fujii H
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1662-70. PubMed ID: 2730064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chromosomic characteristics associated with leukemia and other hemopathies in Costa Rica].
    Castro Volio I; Montero Umaña C; Jiménez Cruz G
    Rev Biol Trop; 1993 Dec; 41(3A):385-92. PubMed ID: 7701079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional and molecular cytogenetic findings of myelodysplastic syndrome patients.
    Yilmaz Z; Sahin FI; Kizilkilic E; Karakus S; Boga C; Ozdogu H
    Clin Exp Med; 2005 Jul; 5(2):55-9. PubMed ID: 16096854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytogenetic findings in patients with primary myelodysplastic syndrome and their prognostic significance. (Analysis of results in 65 patients)].
    Indrák K; Jarosová M; Sulovská I; Scudla V; Hubácek J; Sousková I; Bĕhal K; Svobodová M
    Vnitr Lek; 1994 Sep; 40(9):577-85. PubMed ID: 7975361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution.
    Santana-Davila R; Holtan SG; Dewald GW; Ketterling RP; Knudson RA; Hanson CA; Steensma DP; Tefferi A
    Leuk Res; 2008 Mar; 32(3):407-11. PubMed ID: 17707907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on chromosome aberrations and dyshemopoiesis in myelodysplastic syndromes].
    Jiang Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Oct; 12(5):341-7. PubMed ID: 2151690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of continuous karyotyping in myelodysplastic syndromes].
    Lai YY; Qiu JY; Zhang Y; Zhang Y; Shi Y; He Q; Dang H; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):645-8. PubMed ID: 15634565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic analysis in patients with myelodysplastic syndrome.
    Hu N; Bian M
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(3):135-9. PubMed ID: 2098765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.